Key stats
About KOACT US CNS THERAPEUTICS ACTIVE
Home page
Inception date
Sep 3, 2024
Primary advisor
Samsung Active Asset Management Co., Ltd.
ISIN
KR7490330008
The fund is actively managed ETF that seeks to outperform the daily performance of Solactive US CNS Therapeutics index by mainly investing in U.S. listed companies related to CNS Therapeutics.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.65%
Health Technology98.65%
Bonds, Cash & Other1.35%
Cash1.35%
Stock breakdown by region
North America85.20%
Europe14.80%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
490330 top holdings are Eli Lilly and Company and Vertex Pharmaceuticals Incorporated, occupying 18.87% and 13.80% of the portfolio correspondingly.
490330 assets under management is 6.06 B KRW. It's risen 4.97% over the last month.
490330 fund flows account for −2.88 B KRW (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 490330 doesn't pay dividends to its holders.
490330 shares are issued by Samsung Life Insurance Co., Ltd. under the brand KoAct. The ETF was launched on Sep 3, 2024, and its management style is Active.
490330 expense ratio is 0.50% meaning you'd have to pay 0.50% of your investment to help manage the fund.
490330 invests in stocks.
490330 price has risen by 4.68% over the last month, and its yearly performance shows a −13.72% decrease. See more dynamics on 490330 price chart.
NAV returns, another gauge of an ETF dynamics, showed a −10.88% decrease in three-month performance and has decreased by −15.26% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −10.88% decrease in three-month performance and has decreased by −15.26% in a year.
490330 trades at a premium (0.91%) meaning the ETF is trading at a higher price than the calculated NAV.